W hen president-elect Donald Trump announced that he would nominate Robert F Kennedy Jr to be his secretary of Health and Human Services, the move shocked many. Kennedy, the son of the late senator ...
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...
Harvard University's main teaching hospital will use Echo IQ's AI-based Echosolv tool to detect aortic stenosis (heart valve ...
When president-elect Donald Trump announced that he would nominate Robert F Kennedy Jr to be his secretary of Health and ...
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
Plummeting trust in vaccines could be lethal on its own. But there are also ways Trump’s nominee for Health and Human ...
WASHINGTON (AP) — Robert F. Kennedy Jr., an anti-vaccine activist and environmentalist, for years gained a loyal and fierce ...
Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback